Patrick J. McNamara
Current Organizations / Institutes
The organizations/institutes from the scholar's latest article
Research Subjects
Patrick J. McNamara has a total of 4 co-authors. Here are the top co-authors by number of shared publications:
Bradley D. Anderson
Environmental and Molecular Toxicology, North Carolina State University, Raleigh, North Carolina,1 College of Pharmacy and Nutrition, University of Saskatchewan, Saskatoon, Saskatchewan, Canada,2 Department of Pharmaceutical Chemistry, University of Kuopio, Kuopio, Finland,3 Department of Pharmaceutical Sciences,4 Graduate Center for Toxicology, University of Kentucky, Lexington, Kentucky5
1 shared publicationJane Alcorn
Environmental and Molecular Toxicology, North Carolina State University, Raleigh, North Carolina,1 College of Pharmacy and Nutrition, University of Saskatchewan, Saskatoon, Saskatchewan, Canada,2 Department of Pharmaceutical Chemistry, University of Kuopio, Kuopio, Finland,3 Department of Pharmaceutical Sciences,4 Graduate Center for Toxicology, University of Kentucky, Lexington, Kentucky5
1 shared publicationJeffrey E. Edwards
Environmental and Molecular Toxicology, North Carolina State University, Raleigh, North Carolina, USA
1 shared publicationJuoko Savolainen
Environmental and Molecular Toxicology, North Carolina State University, Raleigh, North Carolina,1 College of Pharmacy and Nutrition, University of Saskatchewan, Saskatoon, Saskatchewan, Canada,2 Department of Pharmaceutical Chemistry, University of Kuopio, Kuopio, Finland,3 Department of Pharmaceutical Sciences,4 Graduate Center for Toxicology, University of Kentucky, Lexington, Kentucky5
1 shared publication
Latest Publications
- 1 April 2005
- Published by American Society for Microbiology in Antimicrobial Agents and Chemotherapy
- Vol. 49 (4) , 1626-8
Role of P-Glycoprotein in Distribution of Nelfinavir across the Blood-Mammary Tissue Barrier and Blood-Brain Barrier
As a first approach in understanding the possible efficacy and toxicity of human immunodeficiency virus protease inhibitors during breast feeding, the milk-to-plasma ratio of nelfinavir was determined in lactating rats. The milk-to-plasma ratio of nelfinavir was determined to be 0.56 ± 0.10 (means ± standard deviations). Western blotting indicated that P-glycoprotein is expressed in rat mammary and brain tissue; however, the multidrug-resistant modulator GF120918 showed a significant effect only at the blood-brain barrier and not at the mammary-epithelial tissue barrier.
- 1 April 2005
- Published by American Society for Microbiology in Antimicrobial Agents and Chemotherapy
- Vol. 49 (4) , 1626-8
Role of P-Glycoprotein in Distribution of Nelfinavir across the Blood-Mammary Tissue Barrier and Blood-Brain Barrier
As a first approach in understanding the possible efficacy and toxicity of human immunodeficiency virus protease inhibitors during breast feeding, the milk-to-plasma ratio of nelfinavir was determined in lactating rats. The milk-to-plasma ratio of nelfinavir was determined to be 0.56 ± 0.10 (means ± standard deviations). Western blotting indicated that P-glycoprotein is expressed in rat mammary and brain tissue; however, the multidrug-resistant modulator GF120918 showed a significant effect only at the blood-brain barrier and not at the mammary-epithelial tissue barrier.